We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+6.12%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$19.8B
AUM Growth
+$677M
(+3.5%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
18.62%
Holding
1,650
New
247
Increased
473
Reduced
518
Closed
280
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$144M |
| 2 |
McDonald's
MCD
|
+$125M |
| 3 |
Procter & Gamble
PG
|
+$117M |
| 4 |
Bruker
BRKR
|
+$72.3M |
| 5 |
Southern Company
SO
|
+$72.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$142M |
| 2 |
Wells Fargo
WFC
|
+$118M |
| 3 |
CVC
CABLEVISION SYS CP NY GRP CL-A
CVC
|
+$74.4M |
| 4 |
Amazon
AMZN
|
+$69.9M |
| 5 |
Bunge Global
BG
|
+$66.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.3% |
| 2 | Healthcare | 16% |
| 3 | Financials | 14.04% |
| 4 | Technology | 12.16% |
| 5 | Communication Services | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Corcept Therapeutics
CORT
$12B
| $290K | ﹤0.01% |
61,761
-39,875
| -39% | -$155K |
|
|
RENX
852
DELISTED
RELX N.V.
RENX
| $290K | ﹤0.01% |
16,565
+8,802
| +113% | +$145K |
|
|
EMC
853
DELISTED
EMC CORPORATION
EMC
| $283K | ﹤0.01% |
10,607
-4,429
| -29% | -$112K |
|
854
Teekay
TK
$985M
| $281K | ﹤0.01% |
32,494
-67,588
| -68% | -$510K |
|
855
Canadian Natural Resources
CNQ
$93.8B
| $280K | ﹤0.01% |
+21,306
| New | +$227K |
|
|
SSRI
856
DELISTED
Silver Standard Resources
SSRI
| $280K | ﹤0.01% |
+50,452
| New | +$266K |
|
|
PFBI
857
DELISTED
Premier Financial Bancorp
PFBI
| $277K | ﹤0.01% |
24,152
+3,260
| +16% | +$36.5K |
|
858
NetSol Technologies
NTWK
$50.6M
| $274K | ﹤0.01% |
39,284
+704
| +2% | +$4.9K |
|
859
Best Buy
BBY
$17.3B
| $273K | ﹤0.01% |
8,425
-14,640
| -63% | -$444K |
|
860
Tilly's
TLYS
$128M
| $273K | ﹤0.01% |
40,877
-16,754
| -29% | -$115K |
|
861
Lincoln National
LNC
$8.81B
| $271K | ﹤0.01% |
6,922
+2,293
| +50% | +$89.5K |
|
862
Travel + Leisure Co
TNL
$4.7B
| $270K | ﹤0.01% |
+7,841
| New | +$249K |
|
|
FENG
863
Phoenix New Media
FENG
$18M
| $268K | ﹤0.01% |
+10,043
| New | +$259K |
|
864
NVIDIA
NVDA
$5.42T
| $267K | ﹤0.01% |
300,720
-12,937,680
| -98% | -$9.87M |
|
865
Crown Castle
CCI
$32.2B
| $265K | ﹤0.01% |
3,062
-2,632
| -46% | -$223K |
|
866
Regeneron Pharmaceuticals
REGN
$80.8B
| $259K | ﹤0.01% |
719
| – | – |
|
|
ABCD
867
DELISTED
Cambium Learning Group, Inc.
ABCD
| $259K | ﹤0.01% |
60,212
+4,610
| +8% | +$20.2K |
|
868
Booking.com
BKNG
$161B
| $257K | ﹤0.01% |
4,975
-250
| -5% | -$12K |
|
|
PHIIK
869
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $257K | ﹤0.01% |
13,569
-4,072
| -23% | -$71.7K |
|
870
ConocoPhillips
COP
$141B
| $256K | ﹤0.01% |
+6,351
| New | +$241K |
|
871
United Rentals
URI
$72.4B
| $254K | ﹤0.01% |
4,077
+2,457
| +152% | +$137K |
|
872
CoreCivic
CXW
$3.19B
| $253K | ﹤0.01% |
7,906
-10,460
| -57% | -$305K |
|
873
Hartford Financial Services
HIG
$39.3B
| $253K | ﹤0.01% |
5,488
+3,459
| +170% | +$145K |
|
874
Kinder Morgan
KMI
$68.7B
| $252K | ﹤0.01% |
14,137
+14,135
| +706,750% | +$231K |
|
875
Spok Holdings
SPOK
$241M
| $245K | ﹤0.01% |
14,030
+11,378
| +429% | +$194K |
|
Similar funds
Acadian Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Acadian Asset Management held 1,650 positions worth $19.8B, up 3.5% from $19.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Acadian Asset Management's Q1 2016 filing shows 247 new, 473 increased, 518 reduced and 280 closed positions. Its largest new stake was AngloGold Ashanti: 4,277,513 shares worth $58.6M. The largest sale was Teva Pharmaceuticals, an estimated $142M.
By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Acadian Asset Management's largest Q1 2016 buy was AngloGold Ashanti: 4,277,513 shares worth $58.6M.
- Acadian Asset Management added most to AT&T in Q1 2016, an estimated $144M increase.
- Acadian Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $142M.
- Acadian Asset Management fully exited Pediatrix Medical in Q1 2016, selling an estimated $34.9M.
- Acadian Asset Management's ten largest holdings make up 19% of its $19.8B portfolio in Q1 2016.
- Acadian Asset Management opened 247 new positions and closed 280 in Q1 2016.
- Acadian Asset Management's portfolio value rose 3.5% quarter-over-quarter to $19.8B.
Based on Acadian Asset Management's 13F filing for Q1 2016, filed 14 Apr 2016.